Insulin glargine/lixisenatide vs Dapagliflozin
National NHS prescribing compared (Prescription Cost Analysis)
Dapagliflozin was dispensed 1,158,086.0× as often as Insulin glargine/lixisenatide in February 2026 — 1,158,086 items versus 1 in England.
1items
Insulin glargine/lixisenatide · February 2026
NHSBSA Prescription Cost Analysis
1,158,086items
Dapagliflozin · February 2026
NHSBSA Prescription Cost Analysis
Figure 1. Insulin glargine/lixisenatide versus Dapagliflozin: national items dispensed by month
▬ Insulin glargine/lixisenatide · ╌ Dapagliflozin
Source: NHSBSA Prescription Cost Analysis, to February 2026
| Measure | Insulin glargine/lixisenatide | Dapagliflozin |
|---|---|---|
| Items, February 2026 | 1 | 1,158,086 |
| Items, last 12 months | 139 | 12,142,822 |
| Net ingredient cost, February 2026 | £49 | £6,553,409 |
See the full profile for Insulin glargine/lixisenatide or Dapagliflozin.